10 Refreshing Cold Soup Recipes For Summer
Samta Pahuja
May 01, 2025
Creamy, cooling, and probiotic-rich—perfect for hydration.
Tomato-based, zesty, and packed with summer veggies.
A sweet twist on gazpacho—watermelon, cucumber, mint.
Rich in healthy fats, blended with lime and herbs.
Sweet peas and mint blend into a vibrant chilled soup.
A tropical, creamy delight with Thai-inspired flavours.
Creamy corn with a hint of spice, served cold.
A French classic—smooth, savory, and elegant.
Earthy and bright, served with sour cream and dill.
Light, herbal, and silky-smooth—great with croutons. Read Next Story
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
2 hours ago
- NDTV
Here's Why & How To Add Broccoli Into Your Daily Diet
Broccoli is incredibly healthy and widely recognised as one of the most nutrient-dense vegetables. Packed with vitamins (like C, K, and A), fibre, antioxidants, and phytochemicals, broccoli supports numerous bodily functions. It's low in calories yet rich in nutrients that help fight inflammation, protect against oxidative stress, improve digestion, and support the immune system. Regular consumption of broccoli can also aid in preventing chronic illnesses, boosting heart and brain health, and even helping with weight management. Keep reading as we share a list of ways in which broccoli can boost your health and ways to add it to your diet. Reasons why broccoli is healthy for you 1. Rich in antioxidants Broccoli contains compounds like sulforaphane and flavonoids, which help neutralise free radicals in the body. These antioxidants protect cells from oxidative damage, lowering the risk of chronic diseases like cancer and heart disease. 2. Supports immune health It is a rich source of vitamin C, which plays a critical role in immune defence. Just one cup of broccoli provides more than 100% of your daily vitamin C requirement, helping your body fight infections and heal faster. 3. Promotes healthy digestion Broccoli is high in dietary fibre, which aids in digestion by promoting regular bowel movements and maintaining a healthy gut microbiome. It also helps prevent constipation and supports long-term digestive health. 4. May help prevent cancer Cruciferous vegetables like broccoli contain glucosinolates, which are known to have cancer-fighting properties. These compounds help in detoxifying carcinogens and slowing the growth of cancer cells, especially in breast, prostate, and colon cancers. 5. Good for heart health Broccoli supports cardiovascular health by lowering cholesterol levels and reducing inflammation. Its high fibre content and antioxidant compounds improve blood vessel function and reduce the risk of heart disease. 6. Aids in detoxification Compounds found in broccoli help activate the liver's detox enzymes. These assist in eliminating harmful toxins from the body, supporting overall metabolic health and liver function. 7. Supports bone health Broccoli is rich in vitamin K and calcium, two key nutrients for bone strength. Consuming broccoli regularly helps maintain bone density and reduce the risk of fractures, especially in older adults. 8. May help with weight management Being low in calories but high in fibre, broccoli can keep you full longer and help reduce overall calorie intake. This makes it a smart addition to any weight loss or weight maintenance plan. Here's are some ways to add broccoli to your diet Lightly steaming preserves nutrients and offers a soft texture. Sprinkle with lemon juice, olive oil, and a pinch of salt. Sauté broccoli with garlic, soy sauce, and sesame oil for a quick Asian-inspired side dish. Blend cooked broccoli with onions, garlic, and low-fat milk or plant-based cream for a nutritious soup. Toss florets with olive oil, salt, pepper, and roast until crispy. Add chilli flakes or parmesan for flavour. Mix grated broccoli with spices and stuff it into whole wheat dough to make fibre-rich, filling parathas. Pulse raw broccoli in a food processor until rice-like, then lightly sauté and season. Whether eaten raw, steamed, roasted, or blended into soups, broccoli is a powerful addition to any balanced diet. Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
Business Standard
3 hours ago
- Business Standard
Servier India introduces 'Ivosidenib'(Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma
VMPL Mumbai (Maharashtra) [India], June 5: Servier India, a subsidiary of the leading French pharmaceutical Servier Group, today announced the launch of Ivosidenib (Tibsovo®), an oral targeted therapy approved in the management of cancer patients with Acute Myeloid Leukemia (AML) and Cholangiocarcinoma, with an isocitrate dehydrogenase-1 (IDH1) mutation. Servier India received the approval on 14th May 2025, from Central Drugs Standard Control Organisation (CDSCO) for the import, sale, and distribution of the medication. Acute myeloid leukemia is a challenging hematological malignancy. Studies indicate that only about 30-40% of AML patients in India receive adequate treatment1, with high mortality rates due to rapid disease progression and infections. Cholangiocarcinomas (CCA) are rare tumours originating from bile duct. Due to their asymptomatic nature they are usually diagnosed when the disease is advanced.2 The announcement marks a significant advancement in management of the mentioned rare and difficult-to-treat cancers in India, addressing a critical unmet medical need. Speaking on the occasion, Mr. Aurelien Breton, Managing Director, Servier India, said, "Our focus is to advance oncology care by bringing innovative, precision medicines to patients who need them the most. By prioritizing access and working to make treatment options affordable to patients, we are dedicated to bridging critical gaps in cancer care across the country. This launch is a significant step forward in our mission to support healthcare providers with targeted treatment options and ultimately improve survival outcomes and quality of life for patients throughout India." IDH1 mutation occurs in approximately 7-14% of AML patients in India3, making targeted mechanisms especially relevant for this subset. "This therapy represents a significant therapeutic option in the treatment of AML and Cholangiocarcinoma. For healthcare professionals, this precision therapy offers a new, effective option that can improve patient outcomes where traditional treatments have limited success. It highlights the benefits of targeted therapy and caliber of innovation in enhancing lives and advancing cancer care in India.", highlighted Dr. Pranav Sopory, Medical and Patient Affairs Director, Servier India. Speaking on the importance of treatment access, Ms. Pratima Tripathi, Commercial Director, Servier India, said: "Our foremost priority is to ensure that the therapy is accessible and affordable to patients across India. We are actively collaborating with healthcare providers, patient advocacy groups, and policymakers to remove barriers and facilitate timely access to this important therapy. Through these partnerships, we are committed to expanding treatment options and making a meaningful difference in the lives of patients." By introducing these advanced therapies, Servier India reaffirms its commitment to advancing innovative cancer treatments that improve clinical outcomes and enhance the quality of life of patients. Disclaimer: This press release is intended solely to share regulatory and medical information regarding the launch; the reference to "Tibsovo" is not intended as a promotional or public advertisement. Use of the therapy is strictly based on a doctor's prescription and clinical discretion. About Servier India Servier India has been committed for over three decades to delivering innovative pharmaceutical solutions that improve the lives of patients and their families across India. Established in 1985 as an affiliate of the leading independent French pharmaceutical Servier Group, the company focuses on therapeutic areas such as Cardiometabolism, Neuroscience, Venous Diseases, and Oncology. Servier India has a strong pan-India presence and a dedicated workforce of around 580 that strives to address critical healthcare challenges with passion and purpose. As part of Servier group operating in over 150 countries, Servier India inherits a rich legacy of scientific excellence and patient-centric innovation. Globally, Servier invests heavily in research and development, focusing on our key therapeutic areas. About Servier Servier is a global pharmaceutical group governed by a Foundation that aspires to serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. As a world leader in cardiometabolism and venous diseases, Servier's ambition is to become a focused and innovative player in oncology by targeting rare cancers. Headquartered in France, Servier relies on a strong geographical footprint; its medicines are available in close to 140 group achieved a revenue of EUR5.9 billion in 2024. Additional Details on Ivosidenib Internationally, Ivosidenib has already received regulatory approvals in more than 42 countries, including the USA, Europe, China, UAE, and South Korea. In the United States, the US FDA approved it in 2019 as a monotherapy and later in May 2022 as a combination treatment with Azacitidine for patients aged 75 and above, or those who cannot tolerate intensive chemotherapy. The European Medical Agency (EMA) gave its approval in May 2023 for use in patients who are not fit for standard induction chemotherapy. In India, the process moved forward in April 2025, when the Subject Expert Committee (SEC) gave a positive recommendation for Ivosidenib. Following this, the DCGI granted approval for the marketing authorization in May 2025
Time of India
4 hours ago
- Time of India
Too hot to handle? Indian origin doctor claims eating this Thai dish left her scarred for life; sues restaurant
Dr. Harjasleen Walia, an Indian origin neurologist from San Jose, has filed a lawsuit against Coup de Thai restaurant in Los Gatos, California, alleging that their spicy "Dragon Balls" dish caused her permanent internal injuries. She claims the dish, made with potent bird's eye chilies, led to chemical burns in her throat, vocal cords, and nostril, despite her request for a milder version. The restaurant denies wrongdoing, stating the dish cannot be made less spicy. A jury trial is scheduled for August, with Walia now representing herself. Tired of too many ads? Remove Ads Doctor Requested Less Spice Medical Complications Tired of too many ads? Remove Ads Dish Contains Highly Spicy Bird's Eye Chili Restaurant Denies Responsibility An Indian origin neurologist from San Jose, California, has filed a lawsuit against a Thai restaurant, alleging a spicy appetizer caused her long-lasting internal injuries. Dr. Harjasleen Walia claims the "Dragon Balls" dish at Coup de Thai in Los Gatos left her with chemical burns and permanent damage after she ate the food in 2023. The incident has sparked a legal battle that is scheduled to go to trial in August News reported that according to court documents filed in Santa Clara County Superior Court, Dr. Walia informed the restaurant staff ahead of time that she could not tolerate spicy food and requested the dish be made mild. The restaurant allegedly agreed to accommodate the request. However, after taking one bite, Walia says she immediately experienced an intense burning sensation across her mouth, throat, tongue, and even her right lawsuit states she "felt her entire mouth, the roof of her mouth, her tongue, her throat and her nose burn like fire." Her "eyes and nose watered, and she began coughing." Despite drinking coconut water and regular water, the burning did not the incident, Dr. Walia alleges she lost her voice and was later diagnosed with internal chemical burns. The complaint describes damage to her vocal cords, esophagus, and nasal passages. The legal filing further claims, "[She] incurred permanent injuries and will forever be damaged."Additionally, she asked the staff for a dairy product — such as milk or yogurt — to counter the spice, but received no assistance. The suit states that 'no milk, ice cream, yogurt, sour cream or other dairy product was provided or offered to Ms. Walia to quell the obvious burning.'Coup de Thai's Dragon Balls are described on the menu as 'spicy chicken ball[s] fried with mint, shallot [and] green onion,' and also include cilantro, kaffir lime leaves, chili, and rice powder. The primary source of heat is Thai bird's eye chili, which measures between 50,000 to 100,000 Scoville Heat Units — significantly hotter than jalapeños and lawsuit claims the use of such chilies made the dish 'unfit for human consumption' and that the restaurant 'failed to take precautions by consulting with health officials or emergency service personnel regarding the risks associated with serving too much Thai chili in an appetizer like Dragon Balls.'Coup de Thai has denied the allegations. The restaurant maintains that the dish cannot be made less spicy since the chilies are already blended into the chicken mixture before cooking. In its October 2023 filing, the restaurant also stated that no other customers have reported similar reactions or required medical Dr. Walia amended her complaint, alleging a new employee mistakenly added extra peppers instead of reducing them as she had requested. In a May 2024 court filing, she also opted to represent herself in the case, moving forward without legal upcoming trial is expected to last five to seven days. The restaurant plans to subpoena Dr. Walia's medical records and request a medical examination. She is seeking compensation for medical expenses, lost earnings, and unspecified damages. A mandatory settlement conference has been scheduled shortly before the trial begins in August.
